Prognostic value and immunological role of MMRN1: a rising star in cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Multimerin 1 (MMRN1) is often down-regulated in cancers and linked to patient prognosis. This protein correlates with tumor immunity and may offer targets for novel anticancer therapies.
Area Of Science
- Oncology
- Molecular Biology
- Bioinformatics
Background
- Multimerin 1 (MMRN1) is a factor V binding protein involved in platelet functions.
- Emerging evidence suggests a role for MMRN1 in cancer, but comprehensive studies are lacking.
Purpose Of The Study
- To investigate the role of MMRN1 in various human tumors using bioinformatics approaches.
- To analyze MMRN1 expression, its correlation with tumor immunity, methylation, and drug sensitivity.
Main Methods
- Utilized The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases.
- Employed bioinformatics tools including GEPIA, HPA, GeneMANIA, cBioPortal, TISIDB, Sangerbox, GSCA, and UALCAN.
- Analyzed MMRN1 expression, immune correlations, methylation, mutations, and drug sensitivity across multiple tumor types.
Main Results
- MMRN1 expression is down-regulated in most cancer types and associated with patient prognosis.
- MMRN1 positively correlates with immune-related genes in most tumors.
- Observed varying methylation and mutation levels; MMRN1 showed negative correlation with drug sensitivity for GW-2580 and TL-1-85.
Conclusions
- MMRN1 is significantly associated with tumor prognosis, immunity, and drug sensitivity.
- MMRN1 represents a potential therapeutic target in oncology requiring further investigation.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...